Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Y2 Health & Society > Block 10 > Flashcards

Block 10 Flashcards

1
Q

Sensitivity

A

True positives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Equation for sensitivity

A

TP/TP+FN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Specificity

A

True negatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Eq for specificity

A

TN/TN+FP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnostic test

A

Any medical test performed to aid the diagnosis or detection of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

4 uses of diagnostic tests

A

Diagnosis
Monitoring
Screening
prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Importance of sensitivity and specificity in informing diagnosis

A

importance of diagnostic accuracy in testing is directly proportional to the tests potential to cause patient consequences and harm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

true positive

A

test indicates disease when there is disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

true negative

A

test indicates no disease when there is no disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

false negative

A

test indicates no disease when there is disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

false positive

A

test indicates disease when there is none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

positive predictive value

A

probability that subjects with a positive screening test truly have the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

negative predictive value

A

probability that subjects with a negative screening test truly dont have the disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

likelyhood ratio

A

likelyhood that a given test result would be expected in a patient with the target disorder compared to the likelyhood that the same result would be expected in a patient without the target disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

screening

A

systematic application of a test to identify individuals at sufficient risk of a specific disorder to warrant further investigation or direct preventative action, amongst people who have not sought medical attention on account of any symptoms of that disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

purpose of screening

A

opportunities for primary prevention and treatment are limited, gives potential for early and more effective treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

which cancers commonly screened for

A

colorectal, breast, cervical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does the PPD test screen for

A

Tuberculosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

prenatal blood tests for

A

foetal abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

newborn bloodspot test for

A

sickle cell, CF, congenital hypothyroidism, metabolic disease (PKU, MCADD, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Opthalmascopy screens for

A

diabetic retinopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ultrasound screens for

23
Q

limitations of screening

A

cost/resources - majority don’t need treatment
adverse effects
stress from FP
unnecessary treatment of FP
stress from prolonging illness with no treatment outcomes
false sense of security from FN

24
Q

pros of good screening

A

early detection of the disease can reduce the risk of death or illness for some people

25
cons of screening
some people get tests, diagnosis and treatment with no benefit, some people get ill or die despite negative screen
26
areas for evaluation when deciding what should be screened for
condition, test, treatment, programme
27
Condition factors
important? epidemiology, natural hustory, detectable risk factor, latent period, cost-effective
28
test factors
simple, safe, precise, validated cut off agreed, acceptable
29
treatment factors
effected EB treatment
30
programme factors
RCT evidence of reduction of mortality/morbidity, benefit outweigh harm, opportunity cost, quality assurance
31
sojourn time
duration of a disease before clinical symptoms become apparent but during which it is detectable by a screening test
32
short sojourn time
rapidly progressing disease, poorer prognosis
33
length bias
overestimation of survival duration among screening-detected cases by the relative excess of slowly progressing cases
34
consequences of length bias
diseases with longer sojourn time easier to detect through screening, on average people with disease detected through screening have better prognosis than through S&S, comparing individuals choosing screened to those not gives distorted picture
35
lead time bias
overestimation of survival duration among screen-detected cases (relative to those detected by signs and symptoms) when survival is measured from diagnosis
36
consequences of lead time bias
survival inevitably longer following diagnosis through screening because of the 'extra' lead time. as a result of this the appropriate measure of effectiveness is deaths prevented, not survival
37
overdiagnosis bias
overestimation of survival duration among screen-detected cases caused by inclusion of pseudodisease
38
pseudodisease
subclinical disease that would not become overt before the patient dies of other causes
39
when does overdiagnosis bias occur
when screen-detected cancers are either non-growing or so slow-growing that they would never cause medical problems
40
PSA testing
prostate specific antigen - protein produced by cells of the prostate gland
41
PSA elevated in
prostate cancer, BPH, prostatis, UTI
42
advantages of PSA screening
can help detect tumours with no symptoms, allows estimation of prostate size and stage, helps doctor predict response to treatment, can be used to monitor men at increased risk
43
disadvantages of PSA screening
early detection may not reduce chance of dying from prostate cancer, over diagnosis -> overtreatment, may give FP (not specific enough) or FN
44
impacts of incontinence on a patient
distress, embarrassment, inconvenience, threat to self esteem, loss of personal control, desire for normalisation, loss of interest in sex, difficulty sleeping
45
impact of chronic dialysis on patients
regular hospital admissions, restriction of leisure time, may have to give up job, increased dependance on dialysis, uncertainness about future, fatigue, limitation of liquids and foods, disrupts relationships, depression, lower self esteem
46
4 sources used when making a clinical decision
``` PARC patient preferences, available resources research evidence clinical expertise ```
47
opportunity cost
loss of other alternatives when one alternative is chosen, amount of money that is alienated by choosing to use it for one project rather than another
48
distributed justice
how we distribute finite resources fairly
49
how to decide ways to distribute healthcare
QALY calculation, waiting list, likelihood of complying with treatment, Pt lifestyle choices, ability to pay
50
confidentiality
pledge of agreement to not divulge or disclose information about patients to others
51
importance of maintaining confidentiality
improves trust between pt and dr, respects autonomy, prevents pt harm, virtuous, human rights act, GMC requirement
52
when can confidentiality be breached
statute (law), consent by patient, public best interest
53
laws which oblige doctors to disclose info
public health act 1984 road traffic act 1988 prevention of terrorism act 1989

Y2 Health & Society (15 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions